OZANIMOD IS AN EFFECTIVE ORAL TREATMENT FOR PATIENTS WITH ULCERATIVE COLITIS REGARDLESS OF MODERATE OR SEVERE ENDOSCOPIC DISEASE ACTIVITY: A POST HOC ANALYSIS OF TRUE NORTH

Laurent Peyrin-Biroulet  ¹     Remo Panaccione  ²     Irina Blumenstein  ³     Millie Long  ⁴     Bincy P. Abraham  ⁵     Anjali Jain  ⁶     Arteid Memaj  ⁶     Chun Wu  ⁶     Vanessa Hobbs  ⁶     Sarah Harris  ⁶     James Canavan  ⁶     Douglas C. Wolf  ^7    
1 Nancy University Hospital, Nancy, France
² Inflammatory Bowel Disease Clinic, Calgary, Alberta, Canada
³ Goethe University Hospital, Frankfurt, Germany
⁴ UNC Chapel Hill, Chapel Hill, United States
⁵ Houston Methodist Academic Institute, Houston, United States
⁶ Bristol Myers Squibb, Princeton, United States
⁷ Atlanta Gastroenterology Associates LLC, Atlanta, United States

Session
Clinical trials in IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)